Skip to content

Clinical trials

Terminated Phase 2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Terminated Country / region: Singapore Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20052
20061
20083
20092
20104
20114
20122
20132
20143
20153
20164
20173
20181
20195
20202
20215
20227
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
Singapore General Hospital6
National Cancer Centre, Singapore5
Boehringer Ingelheim4
Pfizer4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Arcturus Therapeutics, Inc.2
Bayer2
AVEO Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Head and Neck Neoplasms2
Hypertension, Portal2
Hypertension, Pulmonary2
Neoplasm Metastasis2
Non-alcoholic Fatty Liver Disease2
Triple Negative Breast Neoplasms2
Acute Coronary Syndrome1
Acute Kidney Injury1

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.